Applied Biosystems has crept onto the genotyping scene with a three-pillar strategy designed to take aim at market leaders Sequenom and Illumina. But a weak tool market has wounded the sequencing giant, even forcing it to issue a terse warning to investors that deteriorating business will hamstring top-line growth for the remainder of this fiscal year. How will ABI s strategy fare? Subscribe. (https://www.snptech.com/subscribe.htmtarget=_blank)

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.